09/01/2023
Ferropharma opened a new office in Singapore, the biomedical sciences and engineering hub in Asia. It is the first choice location for our partners and customers to develop and produce new biological entities and innovative medicine. It is the key to ferropharma since we can count on a supportive infrastructure, on a high availability of talent, and on an innovative ecosystem. At the same time we enjoy the proximity to the rest of Asia. Companies like , , and recently have also settled a range of commercial activities, including Supply Chain Management, Regulatory Affairs and Medical Affairs in Singapore.
Ferropharma's supplies (BTS) portfolio is the result of profound market research, experience with our customers and creativity to overcome challenges in scarcity of essential materials. Hence, our BTS portfolio provides an integrated and EMA/FDA compliant approach to research, development and manufacturing of novel biopharmaceuticals, biosimilars and ATMPs.